Eagle Mountain Mining Revenu Q/Q
Quel est le Revenu Q/Q de Eagle Mountain Mining?
Le Revenu Q/Q de Eagle Mountain Mining Limited est 350.00%
Quelle est la définition de Revenu Q/Q?
La croissance trimestrielle du chiffre d'affaires, d'une année sur l'autre , correspond à l'augmentation du chiffre d'affaires d'une entreprise par rapport à la performance du trimestre correspondant d'un exercice précédent, exprimée en pourcentage.
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
Revenu Q/Q des entreprises dans Materials secteur sur ASX par rapport à Eagle Mountain Mining
Que fait Eagle Mountain Mining?
Eagle Mountain Mining Limited, together with its subsidiaries, engages in the exploration of mineral resources in Australia and the United States. It explores for copper, gold, and silver deposits. The company primarily focuses on its 100% owned Oracle Ridge Copper Mine in Arizona, the United States. It also owns 100% interest in the Silver Mountain project consisting of 20 patented mining claims, 420 unpatented mining claims, and 6 state exploration permits located in Arizona. The company was incorporated in 2017 and is based in Nedlands, Australia.
Entreprises avec revenu q/q similaire à Eagle Mountain Mining
- Les Hotels de Paris SA a Revenu Q/Q de 346.59%
- Ganesh Housing a Revenu Q/Q de 347.22%
- Deveron UAS a Revenu Q/Q de 347.23%
- Merdeka a Revenu Q/Q de 347.29%
- Sino Harbour a Revenu Q/Q de 348.50%
- Taiga Motors a Revenu Q/Q de 348.53%
- Eagle Mountain Mining a Revenu Q/Q de 350.00%
- C4 Therapeutics a Revenu Q/Q de 350.68%
- Spentex Industries a Revenu Q/Q de 352.36%
- EGL a Revenu Q/Q de 353.48%
- Lemon Tree Hotels a Revenu Q/Q de 355.57%
- Harvest Minerals a Revenu Q/Q de 356.67%
- TG Therapeutics Inc a Revenu Q/Q de 357.05%